Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer

Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer

Abstract Purpose To assess construct validity and responsiveness of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) relative to the Short-Form Six-Dimension (SF-6D) and Assessment of Quality of Life 6-Dimension (AQoL-6D) in patients following treatment for prostate cancer. Methods...

Full description

Bibliographic Details
Main Authors: Norma B. Bulamu, Christine Mpundu-Kaambwa, Michael O’Callaghan, Billingsley Kaambwa
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Cancer
Subjects:
Construct validity
Convergent validity
Discriminant validity
Responsiveness
EPIC-26
AQoL-6D
Online Access:https://doi.org/10.1186/s12885-023-10732-6

Internet

https://doi.org/10.1186/s12885-023-10732-6

Similar Items